ElectroCore Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Public

  • Employees
  • 83

Employees

  • Stock Symbol
  • ECOR

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $4.88
  • (As of Monday Closing)

ElectroCore General Information

Description

electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 200 Forge Way
  • Suite 205
  • Rockaway, NJ 07866
  • United States
+1 (888)
Primary Industry
Therapeutic Devices
Other Industries
Monitoring Equipment
Stock Exchange
NAS
Corporate Office
  • 200 Forge Way
  • Suite 205
  • Rockaway, NJ 07866
  • United States
+1 (888)

ElectroCore Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ElectroCore Stock Performance

As of 16-Nov-2026, ElectroCore’s stock price is $4.88. Its current market cap is $44.7M with 9.2M shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.88 $5.25 $4.37 - $12.70 $44.7M 9.2M 105K -$1.36

ElectroCore Financials Summary

As of 30-Sep-2026, ElectroCore has a trailing 12-month revenue of $38M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 97,071 33,720 97,344 22,911
Revenue 37,967 32,032 25,182 16,030
EBITDA (11,078) (11,996) (10,904) (18,428)
Net Income (12,704) (13,966) (11,886) (18,834)
Total Assets 17,258 18,667 20,471 16,102
Total Debt 9,686 9,403 4,136 626
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ElectroCore Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ElectroCore‘s full profile, request access.

Request a free trial

ElectroCore Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non
Therapeutic Devices
Rockaway, NJ
83 As of 2026

Woburn, MA
 

Mineral Wells, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ElectroCore Competitors (6)

One of ElectroCore’s 6 competitors is NeuroMetrix, a Formerly VC-backed company based in Woburn, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NeuroMetrix Formerly VC-backed Woburn, MA
Alpha-Stim Private Equity-Backed Mineral Wells, TX
Curonix Private Equity-Backed Pompano Beach, FL
Aspen Medical Products Private Equity-Backed Irvine, CA
Mainstay Medical Venture Capital-Backed San Diego, CA
To view ElectroCore’s complete competitors history, request access »

ElectroCore Patents

ElectroCore Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260083960-A1 Devices for nerve stimulation Pending 26-Sep-2024
US-20260069863-A1 Devices for nerve stimulation Pending 06-Sep-2024
US-20260061154-A1 Systems and methods for nerve stimulation Pending 05-Sep-2024
US-20250152939-A1 Systems and methods for promoting general wellness Pending 15-Nov-2023
US-20250099753-A1 Wearable treatment device for non-invasive nerve stimulation Pending 22-Sep-2023 A61N1/0496
To view ElectroCore’s complete patent history, request access »

ElectroCore Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ElectroCore Acquisitions (1)

ElectroCore’s most recent deal was a Merger/Acquisition with NeuroMetrix. The deal was made on 01-May-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
NeuroMetrix 01-May-2025 Merger/Acquisition Therapeutic Devices
To view ElectroCore’s complete acquisitions history, request access »

ElectroCore ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

35.31 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Devices

Subindustry

of 209

Rank

Percentile

To view ElectroCore’s complete esg history, request access »

ElectroCore Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
NeuroMetrix Woburn, MA 1996

ElectroCore FAQs

  • When was ElectroCore founded?

    ElectroCore was founded in 2005.

  • Where is ElectroCore headquartered?

    ElectroCore is headquartered in Rockaway, NJ.

  • What is the size of ElectroCore?

    ElectroCore has 83 total employees.

  • What industry is ElectroCore in?

    ElectroCore’s primary industry is Therapeutic Devices.

  • Is ElectroCore a private or public company?

    ElectroCore is a Public company.

  • What is ElectroCore’s stock symbol?

    The ticker symbol for ElectroCore is ECOR.

  • What is the current stock price of ElectroCore?

    As of 16-Nov-2026 the stock price of ElectroCore is $4.88.

  • What is the current market cap of ElectroCore?

    The current market capitalization of ElectroCore is $44.7M.

  • What is ElectroCore’s current revenue?

    The trailing twelve month revenue for ElectroCore is $38M.

  • Who are ElectroCore’s competitors?

    NeuroMetrix, Alpha-Stim, Curonix, Aspen Medical Products, and Mainstay Medical are some of the 6 competitors of ElectroCore.

  • What is ElectroCore’s annual earnings per share (EPS)?

    ElectroCore’s EPS for 12 months was -$1.36.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process